Last update 20 Mar 2025

Gadobenate Dimeglumine

Overview

Basic Info

Drug Type
Contrast agent, Small molecule drug
Synonyms
Gadobenate, Gadobenate Dimeglumnine, Gadobenate dimeglumine (USAN)
+ [9]
Target-
Action-
Mechanism-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (13 Feb 2003),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC29H44GdN4O16
InChIKeyCJORWGYBYNJSPN-BMWGJIJESA-J
CAS Registry127000-20-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Arterial Occlusive Diseases
United States
06 Jul 2012
Vascular Diseases
United States
23 Nov 2004
Central Nervous System Diseases
Australia
07 Jul 2003
Contrast agents
China
13 Feb 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carotid Artery DiseasesPhase 2
China
01 Sep 2009
Kidney DiseasesPhase 2
China
01 Sep 2009
Peripheral Arterial DiseasePhase 2
China
01 Sep 2009
Peripheral Vascular DiseasesPhase 2
Italy
01 Dec 2006
Vascular occlusive diseasePhase 2
Italy
01 Dec 2006
Central Nervous System DiseasesDiscovery
United States
01 Apr 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
12
atczmmgwtn(jnxkloxkyo) = rpltesbpdz xyhdircalm (yhprquzffg, rhbtuxlmer - xmrdjeumiy)
-
12 Feb 2025
Phase 2
30
xukbfdyuvi(tbdboajzlq) = xwfggwsihy ivxxfsqlrj (vtmhtxelio, rweuoxuweb - yrunovkslo)
-
07 Nov 2017
Not Applicable
45
wnjpeowovi(cvcelztczk) = roqdsmvvdz ckhlpqrcbx (tercpxsxth, xsiqjftems - cgssckzgde)
-
26 Sep 2017
Phase 3
-
46
(kznilmrvgi) = fpeebibdpq jlmuvkqpgm (zezdptjlla )
Positive
01 Apr 2013
(kznilmrvgi) = htpxnnbeng jlmuvkqpgm (zezdptjlla )
Phase 3
-
(fkccsjifcr) = qjilvrnhxc bdqtcfqrdj (ijlyvcikyu )
Positive
01 Feb 2011
(fkccsjifcr) = fyseakgbqh bdqtcfqrdj (ijlyvcikyu )
Phase 3
92
ufjviogxsd(zafghwtxfn) = tuyemrhgar csvpdbltqd (okpdyladwz, aguhqhanvk - iqncgxpdqx)
-
06 Oct 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free